Dynamic interactions of chromatin-related mesenchymal modulator, a chromodomain helicase-DNA-binding protein, with promoters in osteoprogenitors

Stem Cells

Volumn 24, Issue 5, 2006, Pages 1288-1293

  Shur, Irena ^a   Solomon, Ronit ^a   Benayahu, Dafna ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

CHD; Differentiation; Progenitors; Promoters

Indexed keywords

BIGLYCAN; BONE MORPHOGENETIC PROTEIN 4; CHROMATIN RELATED MESENCHYMAL MODULATOR PROTEIN; DNA BINDING PROTEIN; ESTRADIOL; ESTROGEN RECEPTOR; OSTEOCALCIN; PROLACTIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BONE DEVELOPMENT; BONE MARROW CELL; CELL ASSAY; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MESENCHYME CELL; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; OSTEOBLAST; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; TRANSCRIPTION REGULATION;

BASE SEQUENCE; BONE MARROW CELLS; CELLS, CULTURED; DNA HELICASES; DNA-BINDING PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; OSTEOBLASTS; OSTEOGENESIS; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; STEM CELLS; STROMAL CELLS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 33749152530     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2005-0300     Document Type: Article

References (53)

1. Benayahu D. The hemopoietic microenvironment: The osteogenic compartment of bone marrow: Cell biology and clinical application. Hematology 2000;4:427-435.
2. Kassem M, Kveiborg M, Eriksen EF. Production and action of transforming growth factor-beta in human osteoblast cultures: Dependence on cell differentiation and modulation by calcitriol. Eur J Clin Invest 2000;30:429-437.
3. Aubin JE. Regulation of osteoblast formation and function. Rev Endocr Metab Disord 2001;2:81-94.
4. Rodan GA. Control of bone formation and resorption: Biological and clinical perspective. New directions and dimensions in cellular biochemistry. J Cell Biochem. 1998;30/31(suppl):55-61.
5. Mundy GR, Chen D, Zhao M et al. Growth regulatory factors and bone. Rev Endocr Metab Disord 2001;2:105-115.
6. Ducy P, Schinke T, Karsenty G. The osteoblast: A sophisticated fibroblast under central surveillance. Science 2000;289:1501-1504.
7. Manolagas SC, Weinstein RS. New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 1999;14:1061-1066.
8. Spelsberg TC, Subramaniam M, Riggs BL et al. The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. Mol Endocrinol 1999;13:819-828.
9. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
10. Jenkins BD, Pullen CB, Darimont BD. Novel glucocorticoid receptor coactivator effector mechanisms. Trends Endocrinol Metab 2001;12:122-126.
11. Becker M, Baumann C, John S et al. Dynamic behavior of transcription factors on a natural promoter in living cells. EMBO Rep 2002;3:1188-1194.
12. Hager GL, Fletcher TM, Xiao N et al. Dynamics of gene targeting and chromatin remodelling by nuclear receptors. Biochem Soc Trans 2000;28:405-410.
13. Hager GL, Elbi C, Becker M. Protein dynamics in the nuclear compartment. Review. Curr Opin Genet Dev 2002;12:137-141.
14. Bourachot B, Yaniv M, Muchardt C. The activity of mammalian brm/SNF2alpha is dependent on a high-mobility-group protein I/Y-like DNA binding domain. Mol Cell Biol 1999;19:3931-3939.
15. Boyer LA, Logie C, Bonte E et al. Functional delineation of three groups of the ATP-dependent family of chromatin remodeling enzymes. J Biol Chem 2000;275:18864-18875.
16. Bouazoune K, Mitterweger A, Langst G et al. The dMi-2 chromodomains are DNA binding modules important for ATP-dependent nucleosome mobilization. EMBO J 2002;21:2430-2440.
17. Brehm A, Langst G, Kehle J et al. dMi-2 and ISWI chromatin remodelling factors have distinct nucleosome binding and mobilization properties. EMBO J 2000;19:4332-4341.
18. Brown CE, Lechner T, Howe L et al. The many HATs of transcription coactivators. Trends Biochem Sci 2000;25:15-19.
19. Kingston RE, Narlikar GJ. ATP-dependent remodeling and acetylation as regulators of chromatin fluidity. Genes Dev 1999;13:2339-2352.
20. Langst G, Becker PB. Nucleosome mobilization and positioning by ISWI-containing chromatin-remodeling factors. J Cell Sci 2001;114:2561-2568.
21. Peterson CL. Chromatin remodeling enzymes: Taming the machines. Third in review series on chromatin dynamics. EMBO Rep 2002;3:319-322.
22. Narlikar GJ, Fan H.-Y., Kingston RE. Cooperation between complexes that regulate chromatin structure and transcription. Cell 2002;108:475-487.
23. Cosma MP, Tanaka T, Nasmyth K. Ordered recruitment of transcription and chromatin remodeling factors to a cell cycle- and developmentally regulated promoter. Cell 1999;97:299-311.
24. Shur I, Benayahu D. Characterization and functional analysis of CReMM, a novel chromodomain helicase DNA binding protein. J Mol Biol. 2005;23:352:646-655.
25. Marom R, Shur I, Hager G et al. Expression and regulation of CReMM, a chromodomain helicase-DNA-binding (CHD), in marrow stroma derived osteoprogenitors. J Cell Physiol. 2006;207:628-635.
26. Shur I, Socher R, Benayahu D. In vivo association of CReMM/CHD9 with promoters in osteogenic cells. J Cell Physiol 2006;207:374-378.
27. Shur I, Lokiec F, Bleiberg I et al. Differential gene expression of cultured human osteoblasts. J Cell Biochem 2001;83:547-553.
28. Shur I, Marom R, Lokiec F et al. Identification of cultured progenitor cells from human marrow stroma. J Cell Biochem 2002;87:51-57.
29. Grienberg I, Benayahu D. Osteo-Promoter Database (OPD): Promoter analysis in skeletal cells. BMC Genomics 2005;6:46.
30. Cozzi P, Mongelli N. Cytotoxics derived from distamycin A and congeners. Curr Pharm Des 1998;4:181-201.
31. Benayahu D, Shur I, Ben-Eliyahu S. Hormonal changes affect the bone and bone marrow cells in a rat model. J Cell Biochem 2000;79:407-415.
32. Shur I, Kuznetsov S, DeRubeis AR et al. Differential genes expression by human marrow stromal cloned cells. In: Goldberg M, Boskey A, Robinson C, eds. Chemistry & Biology of Mineralized Tissues. Rosemount, IL: American Academy of Orthopaedic Surgeons, 2000:69-74.
33. Marom R, Shur I, Salomon R et al. Characterization of adhesion and differentiation markers of osteogenic marrow stromal cells. J Cell Physiol 2005;202:41-48.
34. Owen M, Friedenstein AJ. Stromal stem cells: Marrow-derived osteogenic precursors. Ciba Found Symp 1988;136:42-60.
35. Orphanides G, Reinberg D. A unified theory of gene expression. Cell 2002;108:439-451.
36. Collingwood TN, Urnov FD, Chatterjee VK et al. Chromatin remodeling by the thyroid hormone receptor in regulation of the thyroid-stimulating hormone α-subunit promoter. J Biol Chem 2001;276:34227-34234.
37. Dilworth FJ, Fromental-Ramain C, Yamamoto K et al. ATP-driven chromatin remodeling activity and histone acetyltransferases act sequentially during transactivation by RAR/RXR in vitro. Mol Cell 2000;6:1049-1058.
38. Veenstra GJC, Wolffe AP. Gene-selective developmental roles of general transcription factors. Trends Biochem Sci 2001;26:565-571.
39. Wolffe AP, Urnov FD, Guschin D. Co-repressor complexes and remodelling chromatin for repression. Biochem Soc Trans 2000;28:379-386.
40. Clement-Lacroix P, Ormandy C, Lepescheux L et al. Osteoblasts are a new target for prolactin: Analysis of bone formation in prolactin receptor knockout mice. Endocrinology 1999;140:96-105.
41. Nanbu-Wakao R, Fujitani Y, Masuho Y et al. Prolactin enhances CCAAT enhancer-binding protein-beta (C/EBP beta) and peroxisome proliferator-activated receptor gamma (PPAR gamma) messenger RNA expression and stimulates adipogenic conversion of NIH-3T3 cells. Mol Endocrinol 2000;14:307-316.
42. Zhou S, Turgeman G, Harris SE et al. Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells. Mol Endocrinol 2003;17:56-66.
43. Karsenty G. Minireview: Transcriptional control of osteoblast differentiation. Endocrinology 2001;142:2731-2733.
44. Lian JB, Javed A, Zaidi SK et al. Regulatory controls for osteoblast growth and differentiation: Role of Runx/Cbfa/AML factors. Crit Rev Eukaryot Gene Expr 2004;14:1-41.
45. Olsen BR, Reginato AM, Wang W. Bone development. Annu Rev Cell Dev Biol 2000;16:191-220.
46. Janssens K, Ten Dijke P, Janssens S et al. Transforming growth factor-β1 to the Bone. Endocr Rev 2005;26:743-774.
47. McCarthy TL, Chang WZ, Liu Y et al. Runx2 integrates estrogen activity in osteoblasts. J Biol Chem 2003;278:43121-43129.
48. Benayahu D. Estrogen effects on protein expressed by marrow stromal osteoblasts. Biochem Biophys Res Commun 1997;233:30-35.
49. Coss D, Yang L, Kuo CB et al. Effects of prolactin on osteoblast alkaline phosphatase and bone formation in the developing rat. Am J Physiol Endocrinol Metab 2000;279:E1216-E1225.
50. Barkhem T, Nilsson S, Gustafsson JA. Molecular mechanisms, physiological consequences and pharmacological implications of estrogen receptor action. Am J Pharmacogenomics 2004;4:19-28.
51. Wagner EF. Functions of AP1 (Fos/Jun) in bone development. Ann Rheum Dis. 2002;61(suppl 2):ii40-ii42.
52. Benayahu D, Akavia UD, Socher R et al. Gene expression in skeletal tissues: Application of laser capture microdissection. J Microscopy 2005;220:1-8.
53. Shur I, Socher R, Benayahu D. Dexamethasone regulation of cFOS mRNA in osteoprogenitors. J Cell Physiol 2005;202:240-245.